Introduction
Hematopoiesis is characterized by the differentiation of multipotent stem cells (hematopoietic stem cells; HSCs) into different progenitors that are progressively committed to restricted lineages, terminally becoming one specific type of mature blood cells . Homeostasis of this process is maintained by the coordinated regulation of proliferation versus the maturational advancement of progenitor cells, which defines the proportion of cell populations at each specific developmental stage. Currently, hematopoietic progenitor cells are accurately classified according to their developmental potentials, as summarized in Supplementary Figure 1 . Each type of progenitor harbors a specific cell surface phenotype, which is distinguished by the expression profiles of certain surface proteins such as c-kit, Sca-1, IL-7 receptor (IL-7R), CD34 and Fcg receptor (FcgR) (Akashi et al, 2000a, b; Weissman et al, 2001) .
Today, mammalian polycomb group (PcG) proteins are implicated as being involved in hematopoiesis Lessard and Sauvageau, 2003b) . PcG genes were originally identified in the Drosophila as transcription repressor genes, and are involved in the maintenance of correct spatial and temporal expression of the homeotic genes during development in large protein complexes (Wismar, 2001 ). Many mammalian PcG proteins appear to play roles in hematopoiesis in a variety of fashion: for example, enhancement of lymphopoiesis via activation of proliferation , control of B-cell development through histone H3 methylation and immunoglobulin heavy chain (IgH) rearrangement (Su et al, 2003) and generation of self-renewing HSCs (Lessard and Sauvageau, 2003a; Park et al, 2003) . Of these, a population of PcG proteins harbor different repeats of a unique mbt domain, which was initially described in the Drosophila lethal(3)malignant brain tumor (l(3)mbt) protein. Although it is predicted that the mbt domain might possess a strong transcription-repressing activity (Boccuni et al, 2003) , the physiological function(s) of the mbt-containing PcG proteins are yet unclear. Interestingly, the human homolog of the l(3)mbt gene (H-L(3)MBT gene) maps to chromosome 20q12, within a common deleted region associated with myeloid hematopoietic malignancies (Koga et al, 1999; Bench et al, 2000; MacGrogan et al, 2001; Li et al, 2004) . This may also suggest a possible linkage of the mbt-containing PcG proteins and hematopoiesis.
From databases, we have newly isolated a putative PcG molecule, termed MBT-1. The MBT-1 structurally resembles the H-L(3)MBT. In addition, the human MBT-1 gene (hMBT-1) localizes to chromosome 6q23, one of the most frequently modified loci in some types of acute leukemia cells (Hayashi et al, 1990; Hirata et al, 1992; Offit et al, 1994; Merup et al, 1998; Sundareshan et al, 2003) . Together, MBT-1 might also play a role in hematopoiesis. In this study, we provide evidence that MBT-1 specifically regulates the maturational advancement of myeloid progenitors during differentiation, involving the enhancement of cyclin-dependent kinase inhibitor activities.
Results

MBT-1, a new PcG gene expressed in hematopoietic progenitor cells, localized to human chromosome 6q23
We isolated MBT-1 as a putative PcG protein. Like many PcG proteins, MBT-1 contains nuclear localization signals (NLS) and a sterile alpha motif (SAM)/SPM domain, believed to function in the polymerization of proteins (Bornemann et al, 1996) , at the C-terminus ( Figure 1A ). The strict localization of MBT-1 protein to the nucleus was evident by a confocal microscopic analysis of Chinese hamster ovarian carcinoma (CHO) cells transfected with a FLAG-tagged MBT-1 gene ( Figure 1B ). Similar to l(3)mbt (and its human homolog H-L(3)MBT), MBT-1 is characterized by three repeats of the mbt motif. Interestingly, the mouse homolog of MBT-1 harbors a unique glutamine-rich domain (poly-Q), which is absent in human MBT-1. This domain probably strengthens protein-protein interactions, resulting in the polymerization/ aggregation of nuclear molecules, as in macrophage glutamine repeat protein-1 (GRP-1) (Cox et al, 1996) . Other components are, however, highly conserved in human and mouse clones ( Figure 1A ).
Hematopoietic cells, in the fetal liver of the mouse embryo and the bone marrow of adult mouse, displayed comparable levels of MBT-1 expression throughout development when analyzed by RT-PCR ( Figure 1C ). In addition, all types of hematopoietic progenitor cells in the murine fetal liver expressed the MBT-1 gene ( Figure 1D ).
Next, we analyzed the expression kinetics of MBT-1 during the differentiation of immature hematopoietic cells using a leukemia cell line. As shown in Figure 1E , in TF-1 cells (a human erythroleukemia cell line derived from myeloid progenitor cells; Kitamura et al, 1989) , the MBT-1 expression level significantly increased (approximately 8-to 10-fold) within 2 h in response to induction of differentiation by 2-O-tetradecanoylphorbol 13-acetate (TPA). It was then rapidly downregulated, and displayed the lowest level, which was even lower than the endogenous level before stimulation, during a late stage of differentiation, that is, 12 h after stimulation. Similar results were also obtained by using other leukemia cell lines such as HL-60 and KG-1 (data not shown). In addition to hematopoietic cells, MBT-1 is expressed in multiple mouse tissues, when analyzed by Northern blotting ( Figure 1F ).
Embryonic lethality of MBT-1
À/À mice due to anemia
To address the potential contribution of MBT-1 to hematopoiesis in vivo, we generated mice incapable of making MBT-1 (MBT-1
), by replacing exon 15 and a part of the intron of the MBT-1 gene with a neomycin resistance gene (neo r ) via homologous recombination in embryonic stem (ES) cells (Figure 2A ). When timed pregnancies from intercross breeding of mice carrying the mutation in the heterozygous state (MBT-1 þ /À ) were analyzed, all of the MBT-1 À/À embryos died during a late embryonic stage (between E17.5 and E19.5) ( Figure 2B ). Complete lack of the MBT-1 expression was Figure 2D ). In addition, hematocrit (Ht) levels were lower in MBT-1
(n ¼ 6-8 for each)). These results, together with the normal development of other organs, as assessed by histological analysis (Supplementary Figure 2) , suggest that the loss of MBT-1 disturbed definitive erythropoiesis, resulting in embryonic lethality of MBT-1 À/À mice caused by anemia.
Inefficient maturation of MBT-1 À/À myeloid lineage cells
In addition to erythrocytes, other types of mature myeloid lineage cells were also decreased in the MBT-1 À/À fetal liver at a late embryonic stage (E17.5). As displayed in Figure 3A , the absolute number of granulocytes (Gr-1 þ Mac-1 þ ) was approximately 14 times less in MBT-1
were also markedly decreased in number. However, in sharp contrast to the decrease of mature myeloid cells, the absolute numbers of the relevant upstream progenitors (megakaryocyte/erythrocyte progenitor (MEP) and granulocyte/macrophage progenitor (GMP); refer Supplementary Figure 1) were markedly increased in MBT-1 À/À animals ( Figure 3B ). Common myeloid progenitor (CMP) cells, the upstream precursors for GMP and MEP cells, were also increased in number ( Figure 3B) . Similarly, the proportion of lineage markers-negative (Lin À ) progenitor cells in total FLCs was increased in MBT-1 Figure 3C ). These observations strongly suggest that the maturational transition of progenitors toward mature myeloid lineage cells is defective, resulting in the accumulation of immature progenitor cells in MBT-1 À/À mice.
In order to assess whether the proliferative potentials of these myeloid progenitor cells were influenced in MBT-1 À/À mice, we compared the incorporation of BrdU by those cells from MBT-1 þ / þ and MBT-1 À/À animals. As shown in Figure 3D , the incorporation of BrdU was essentially equivalent in MBT-1 þ / þ and MBT-1 À/À animals in each type of progenitor cells, clearly indicating that the lack of MBT-1 does not affect proliferation of the progenitor cells. In addition, the proportions of Annexin V (a marker for apoptotic cells)-positive cells in mature granulocytes and macrophages were equiva-
; n ¼ 5 each). Therefore, decrease of mature myeloid cells in MBT-1 À/À animals was not due to accelerated apoptosis of those cells.
In contrast to myeloid lineage cells, the decrease in lymphocyte numbers was less marked in MBT-1 À/À animals. The proportion of B220 high þ mature B cells in the fetal liver was slightly decreased in MBT-1 À/À mice ( Figure 3E ), and T-cell (thymocyte) differentiation was almost comparable in mutant and wild-type mice, both in cell number and in maturation profiles ( Figure 3F ). Similarly, the number of common lymphoid progenitor (CLP) cells was equivalent in mutant and wild-type embryos at E17.5 ( Figure 3G ). In addition, no difference was observed in BrdU incorporation by CLP cells in wild-type and mutant mice ( Figure 3H ). Thus, MBT-1 predominantly regulates myelopoiesis. Figure 4A ; 48% for MBT-1 þ / þ versus 56% for MBT-1 À/À ). Thus, the maturational defect causing anemia in MBT-1 À/À mice may exist between the MEP and the mature erythrocyte stages, but not between the CMP and the MEP stages. To address this hypothesis, we performed the colonyforming cell (CFC) assay using purified MEP cells. As shown in Figure 4E , when equal numbers of
MEP cells were cultured in methylcellulose in the presence of SCF, IL-3, IL-6 and Epo for 12 days, many colonies containing large clusters of mature erythrocytes developed from MBT-1 þ / þ MEP cells, whereas much less of these emerged from Figure 4F ). Most of the colonies derived from MBT-1 À/À MEP cells consisted of nonclustered homogenous round cells that were apparently different from mature cells ( Figure 4E ). These cells were c-kit high þ , indicating their immature status, in contrast to low or no c-kit expression on the mature cells ( Figure 4G ). Therefore, MBT-1 À/À MEP cells cannot efficiently differentiate to mature erythrocytes, and remain at the MEP stage and continue to proliferate. (Weston and Parish, 1990) . The labeled CMP cells were differentiated in vitro. Thereafter, cells were stained for CD34, FcgR and Gr-1, and the CFDA-SE intensities for newly developed MBT-1 þ / þ or MBT-1 À/À GMP cells at the same maturational state (displaying the same CD34/FcgR levels) were analyzed. We estimated the numbers of cell division undergone during the period, based on the CFDA-SE levels before and after the culture (both are indicated in Figure 5A ). Overall, as we predicted, MBT-1 À/À cells had undergone a larger number of cell divisions than MBT-1 þ / þ cells did before reaching the same maturation stage ( Figure 5A ). As an alternative analysis, the maturational states of MBT-1
MBT-1
harboring an identical CFDA-SE intensity were compared by examining Gr-1 expression. As demonstrated in Figure 5B , p27 KIP1 and p18
INK4c
, showed comparable expression levels in mutant and wild-type FLCs ( Figure 6A ). In addition, the expression levels of various genes known to be involved in myelopoiesis such as PU.1, GATA-1, CEBP/a, AML-1, GATA-2, c-mpl, c-Myb or EpoR (Akashi et al, 2000a; Barreda and Belosevic, 2001; Friedman, 2002) were not altered in MBT-1 À/À FLCs (data not shown). The p57 KIP2 protein inhibits cyclins and cdks of multiple types with the greatest influence on cdk2 complexes (Yan et al, 1997) , and p57 KIP2 -deficient (p57 KIP2À/À ) animals display a maturational delay in multiple tissues (Yan et al, 1997; Zhang et al, 1997) . Hence, we hypothesized that MBT-1 may promote maturational advancement of myeloid progenitor cells by inducing cell cycle arrest preceding transition points via enhancement of p57 KIP2 expression.
Like the MBT-1 gene, the p57 KIP2 level also displayed a transient expression spike during the maturation process when assessed in TF-1 cells ( Figure 6B) . Importantly, the levels of both MBT-1 and p57 KIP2 are markedly downregulated during a late stage of maturational transition ( Figure 6B ). This response should make the cell cycle interference via the MBT-1-p57 KIP2 pathway restricted to the transitional period of progenitor cell maturation, and preserve normal cell proliferation after transition. Indeed, the lack of MBT-1 did not influence BrdU incorporation by all three myeloid progenitors (refer Figure 3D) .
In order to test the actual involvement of p57 KIP2 in the downstream functional pathway of MBT-1, we addressed whether overexpression of p57 KIP2 via adenovirus infection would overcome the maturational deficiency in MBT-1 À/À CMP cells during in vitro culture. As shown in Figure 6C and D, the pAd-p57 KIP2 infection significantly improved the 
MBT-1 associates with Rnf2 (Ring1b)
A hallmark of PcG proteins is that they form multimeric DNAbinding complexes, consisting of both PcG and non-PcG proteins Lessard and Sauvageau, 2003a, b) . In vertebra, at least two distinct types of PcG complex have been identified. The 'HPC-HPH' complex contains Bmi-1, HPH, HPC, Ring1a (also called Ring1) and Rnf2 (also called Ring1b), and appears to be involved in stable maintenance of gene silencing. The other, the 'EED-EZH' complex, consists of Eed, Ezh2 and YY1, making the 'epigenetic mark' necessary for the establishment and memory trace of the silent state (Poux et al, 2001; Raaphorst et al, 2001; Satijn et al, 2001; Cao et al, 2002; Lessard and Sauvageau, 2003a, b) .
In order to address whether MBT-1 may also participate in a protein complex, we performed a two-hybrid screen using a complementary DNA library prepared from E17 mouse embryos. Up to 39 positive clones that were shown to synthesize MBT-1-binding proteins were sequenced. Of these, one clone encoded Rnf2. We confirmed the association between MBT-1 and Rnf2 in the yeast, by using the full-length cDNA fragments of MBT-1 and Rnf2. As shown in Figure 7A , the yeast cells expressing both MBT-1 and Rnf2 ( Figure 7A , a) survived in the absence of histidine and adenine, and revealed a-galactosidase activity ( Figure 7A, a) , while those producing only MBT-1 ( Figure 7A, b) did not. This result confirmed the in vivo interaction of MBT-1 and Rnf2 in yeast cells. In agreement with this result, MBT-1 and Rnf2 co-immunoprecipitated each other in mammalian cells, when tested by using cell lysates from 293T cells transfected with tagged MBT-1 and Rnf2 genes ( Figure 7B ). Together, these results clearly identify Rnf2 as a binding partner of MBT-1.
Within the 'HPC-HPH' PcG complex, Rnf2 associates with Bmi-1 through the ring finger domain of Bmi-1, and this interaction is essential for Bmi-1's ability to mediate cell cycle control by means of the Cdkn2a (Ink4a/ARF) locus (Alkema et al, 1997; Jacobs et al, 1999; Voncken et al, 2003) . This was also proven by a significant increase in the expression level of p16
INK4a in both Bmi-1 À/À and Rnf2 À/À cells (Park et al, 2003; Voncken et al, 2003) . Based on the association of MBT-1 and Rnf2, we also assessed whether the p16 INK4a level may increase in the absence of MBT-1. Zindy et al (1997) .
Discussion
In this study, the newly characterized MBT-1 represents a novel form of hematopoietic regulation: controlling the maturational advancement of myeloid progenitors at transition points without influencing their proliferative potentials, in part by transiently enhancing the expression levels of the cdk inhibitor p57
KIP2 . The MBT-1 À/À mice thus revealed accumulation of immature progenitor cells and a marked reduction of mature blood cells in the myeloid lineage, leading mice to death due to overt anemia during a late embryonic stage. The maturational defect of myeloid progenitors in MBT-1 À/À mice is cell autonomous, because the inefficient maturation of purified progenitor cells is also apparent (i) in vitro when differentiated either on OP-9 stromal feeder cells or on methylcellulose supplemented with appropriate sets of cytokines and growth factors, and (ii) in vivo after being transplanted into lethally irradiated recipient mice. The association of MBT-1 and Rnf2, together with the fact that MBT-1 structurally resembles l(3)mbt (and its human homolog H-L(3)MBT) and that a substantial transcriptionrepression activity has been proposed for the function of the mbt repeat (Boccuni et al, 2003) , strongly supports the idea that MBT-1 belongs to PcG. Interestingly, the expression level of p16
INK4a
, which is the target gene of Bmi-1, which also forms a complex with Rnf2, was not increased in MBT-1 À/À cells. Thus, the fine composition of PcG complexes may differ at each target gene, in each cell type and during each developmental stage, as suggested by accumulating evidence (Strutt and Paro, 1997; Satijn and Otte, 1999; Gunster et al, 2001; Raaphorst et al, 2001; Voncken et al, 2003) . Alternatively, an unknown PcG complex containing MBT-1 and Rnf2, which is different from the two known complexes in vertebra ('HPC-HPH' and 'EED-EZH' complexes), might exist and play a distinct role. Further studies will clarify the PcG complex containing MBT-1.
The enhancement of p57 KIP2 expression may not be the sole machinery downstream of MBT-1, since the rescue by p57 KIP2 overexpression was not as complete as to recover the differentiation potency in mutant cells to that in wild-type cells ( Figure 6C ). This may also be consistent with the fact that p57 KIP2À/À mice are not embryonic lethal (Yan et al, 1997; Zhang et al, 1997) , implying that p57 KIP2À/À mice may not harbor, if any, as striking a deficiency in erythropoiesis during embryonic stages as do MBT-1 À/À mice, although a detailed analysis of hematopoiesis has not yet been reported (Yan et al, 1997; Zhang et al, 1997) . The putative p57 KIP2 -independent pathway(s) for maturational regulation by MBT-1 is an area open to further clarification. Since PcG proteins are gene repressors, the enhancement of p57 KIP2 gene expression by MBT-1 is intriguing. Thus, it is possible that suppression of certain gene(s) by MBT-1 may consequently result in upregulation of p57 KIP2 expression. Further efforts are required to identify the direct target genes of MBT-1.
The function of MBT-1 is unique among the many PcG proteins involved in hematopoiesis, since their roles so far have been apparent in the regulation of proliferation of immature and/or mature lymphoid lineage cells Lessard and Sauvageau, 2003b) . Interestingly, however, the regulation of maturation by MBT-1 and the proliferative control exerted by certain PcG proteins employ a similar mechanistic pathway: regulation of the expression of cdk inhibitors. For example, Bmi-1 suppresses the expression of the cdk inhibitors p16
INK4a and p19 ARF , hence supporting the proliferation of HSCs and lymphocyte progenitors (Jacobs et al, 1999; Lessard and Sauvageau, 2003a; Park et al, 2003) . Likewise, a different PcG member mel-18 also diminishes the p16
INK4a expression and augments proliferation of T-and Blymphocyte lineage cells (Akasaka et al, 1997; Jacobs et al, 1999) . Hence, the expression of cdk inhibitors appears to be differentially regulated by nuclear factors during the maturation and proliferation of various hematopoietic lineage cells.
Another important molecular characteristic of MBT-1 is its transient alteration in expression levels at cell maturational transition points: immediate upregulation followed by rapid downregulation, upon maturation-inducing stimuli. This response may contribute to restricting the cell cycle arrest mediated by the MBT-1-p57 KIP2 pathway during the maturational transition, which allows cells to maintain a normal proliferative potential at the subsequent developmental stage. Whether this expression kinetics of MBT-1 gene is also observed during the maturation of primary hematopoietic progenitors, and the mechanism for such kinetic regulation of MBT-1 gene expression, will require further investigations.
MBT-1 À/À myeloid progenitor cells reveal deficiencies in maturational advancement, but this blockade was partial in two aspects. First, some MBT-1 À/À CMP cells attain a leaky differentiation to the GMP stage, although they had undergone increased numbers of cell divisions during this maturation process. Second, despite the MBT-1 mRNA expression in all types of progenitors including CLP cells, lymphopoiesis is not affected in MBT-1 À/À mice. Similarly, maturation of CMP cells to the MEP stage appears normal. This incomplete phenotype of MBT-1 À/À cells may be explained by functional redundancy with other MBT-1-like molecules that are also expressed in hematopoietic progenitors. Indeed, several sequences displaying similarities with MBT-1 possessing mbt repeats, including H-L(3)MBT, have been published (Koga et al, 1999; Bench et al, 2000 Bench et al, , 2001 Usui et al, 2000; MacGrogan et al, 2001; Wismar, 2001; Li et al, 2004) or have appeared in databases, although their functions are still unknown. In fact, we found that some of these molecules have differential expression in hematopoietic progenitor cells, as assessed by RT-PCR (data not shown). Their functional understanding will help to evaluate the possible redundancy in these MBT-1-like molecules.
Although the identification and characterization of MBT-1 has provided novel insights into the regulation of hematopoiesis, deletion of MBT-1 did not solely induce leukemia. However, the phenotype of MBT-1 À/À mice, which is characterized by accumulation of myeloid progenitor cells, might suggest a possible role of MBT-1 dysfunction in development of preleukemia. Identification of (specific) modifications of the MBT-1 gene in a large-scale screening of leukemia cells from patients will be necessary to further assess the putative correlation of leukemogenesis and MBT-1 dysfunction. On the other hand, the full-length Rnf2 cDNA fragment was cloned into the pGADT7 vector to produce a fusion protein of Rnf2 and GAL4-activating domain. Resulting plasmids were transformed into the yeast cell line AH109 harboring the reporter genes for ADE2, HIS3 and MEL1 that are under the regulation of GAL4 upstream activating sequences (UASs). The pGBKT7-containing AH109 cells can grow in the absence of tryptophan (Trp), while the pGADT7 allows AH109 cells to survive without leucine (Leu). When MBT-1 and Rnf2 associate in AH109 cells, the three reporter genes are expressed, thus allowing the cells to grow on a selective media plate lacking histidine (His) and adenine (Ade), as well as to express a-galactosidase activity. AH109 cells were transformed with (a) pGBKT7-MBT-1 and pGADT7-Rnf2, or (b) pGBKT7-MBT-1 and pGADT7-vector (without the Rnf2 sequence). Both transformants survived on a ÀLeu/ÀTrp media plate (left), but only (a) grew and revealed a-galactosidase activity on a ÀLeu/ÀTrp/ÀHis/ÀAde/X-agal media plate (right). (B) Co-immunoprecipitation. Both or either of FLAG-tagged MBT-1 and V5-tagged Rnf2 were expressed in 293T human kidney cells. Cell lysates were immunoprecipitated by using either anti-FLAG or anti-V5 antibody conjugated with agarose beads. Precipitants were separated by SDS-PAGE, blotted on a membrane and specific signals were detected by Western blotting. IP: immunoprecipitation; WB: Western blotting.
Materials and methods
Isolation of the MBT-1 gene
The human MBT-1 gene (appearing as KIAA1798 or L(3)MBT-like 3 in the database with accession number XM_027074) was isolated from a database. The mouse MBT-1 clone was isolated by BLAST analysis of the mouse EST clones (accession number NM_172787). Both human and mouse MBT-1 cDNA clones were purified from cDNA libraries generated from human or mouse bone marrow cells using cDNA fragments as probes. These probes were amplified by RT-PCR from human or mouse bone marrow RNA using primers generated based on the database sequence of mouse or human MBT-1 (primer sequences will appear in the 'Primer' section).
Transfection and confocal microscopic analysis
The precise procedure is available online.
Generation of MBT-1
À/À mice The MBT-1 À/À mice were generated via homologous recombination in ES cells. The detailed procedure is available online.
Serological reagents and flow cytometry
All antibodies were purchased from BD Pharmingen or eBioscience. Details are available online.
In vitro and in vivo differentiation of progenitor cells
The in vitro maturation of CMP or MEP cells and their analysis were performed mainly according to the previous reports by Akashi et al (2000b) and Traver et al (2001) . The precise procedures are available online. For reconstitution experiments, B6 (Ly9.1 À ) mice were lethally irradiated (900 rad) and injected with 5 Â10
5 FLCs (Ly9.1 þ ) isolated from MBT-1 þ / þ or MBT-1 À/À fetal livers (E14.5). At 4 weeks after the transplantation, peripheral blood cells were analyzed for Ly9.1 þ -donor-derived Gr-1 þ cells. Cytokines and growth factors were purchased from R&D Systems.
BrdU-incorporation assay
FLCs were incubated in IMDM (containing FBS at 10%) at 2 Â10 6 cells/ml in the presence of 10 mM BrdU at 371C for 30 min. After extensive washes with PBS, cells were prestained for PE-FcgR. This procedure also avoids non-antigen-specific binding of immunoglobulins to the Fcg receptors expressed on the progenitor cells. Thereafter, both Lin þ and Sca-1 þ cells were depleted by using MACS columns (Milteny Biotec) along with Lineage Cell Depletion kit (Milteny Biotec) and Anti-Sca-1 Microbeads (Milteny Biotec). Negative fractions were surface stained for APC-c-kit, PerCP-CD34 and PE-FcgR. Cells were then fixed, permeabilized and treated with DNase, followed by staining for BrdU by using the BrdU (FITC) Flow Kit (BD Bioscience). Cells were analyzed using the FACSCalibure cytometer (Becton Dickinson) for BrdU þ cells in each type of myeloid progenitors.
CFDA-SE labeling and cell division analysis
Approximately 5000 CMP cells sorted from E14.5 MBT-1 þ / þ or MBT-1 À/À FLCs were labeled with CFDA-SE by incubating the cells in the presence of 0.8 mM CFDA-SE for 15 min. After an extensive wash, cells were cultured on irradiated OP-9 cells in the presence of mouse SCF (10 ng/ml), mouse IL-11 (10 ng/ml) and mouse Tpo (10 ng/ml) for 48 h. Thereafter, nonadherent cells were stained for CD34, FcgR and Gr-1, and analyzed using a FACSCalibure cytometer. The number (n) of cell division undergone during the culture period was estimated as n ¼ log 2(CFDA-SE intensity before the culture/CFDA-SE intensity after the culture).
Adenovirus infection and in vitro differentiation of progenitor cells
The adenovirus vectors used in this work were created by using the pAd/CMV/V5-DEST Gateway system (Invitrogen) and either a LacZ sequence or mouse cDNA of p57 KIP2 . The procedures of virus infection, cell maturation and cell analysis are available online.
Analysis of the kinetics of gene expression upon maturation induction TF-1 cells were stimulated by 100 nM TPA supplemented in the culture medium. At 0, 2, 12 and 24 h after TPA-induced maturation, cells were harvested to isolate RNA. Expression levels of human MBT-1, p57 KIP2 and actin were analyzed by semiquantitative RT-PCR. PCR products were separated on an agarose gel. The same procedures were applied when HL-60 and KG-1 cells were used.
Yeast two-hybrid screening
Yeast two-hybrid assay was performed using MATCHMAKER GAL4 Two-hybrid system 3 (BD Biosciences). The precise procedure is available online.
Immunoprecipitation
Primers
Primer sequences used for RT-PCR in this work are available online.
Microarray analysis
Microarray analyses were performed by using total RNA (5 mg/ experiment required) and mainly Affymetrix chips at the Microarray core facility at the University of Texas Southwestern Medical Center at Dallas.
Supplementary data
Supplementary data are available at The EMBO Journal Online.
